SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-000243
Filing Date
2020-01-02
Accepted
2020-01-02 16:04:50
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4120
  Complete submission text file 0001209191-20-000243.txt   5494
Mailing Address 1621 BAYSIDE DR CORONA DEL MAR CA 92625
Business Address
ANIDO VICENTE JR (Reporting) CIK: 0001207633 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36152 | Film No.: 20501525

Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)